Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arbutus Biopharma Cp (NQ: ABUS )

3.840 USD +0.090 (+2.40%)
Official Closing Price Updated: 7:51 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,075,600
Open 3.900
Bid (Size) 3.840 (388)
Ask (Size) 3.910 (5)
Prev. Close 3.750
Today's Range 3.740 - 3.980
52wk Range 0.8800 - 9.020
Shares Outstanding 55,167,997
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of Chronic Hepatitis B Virus
From GlobeNewswire News Releases
Arbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate Update
From GlobeNewswire News Releases

Performance

YTD
+5.49%
+5.49%
1 Month
-1.03%
-1.03%
3 Month
-15.23%
-15.23%
6 Month
+31.96%
+31.96%
1 Year
+34.74%
+34.74%

More News

Read More
Arbutus Announces 2021 Corporate Objectives and Provides Financial Update
From GlobeNewswire News Releases
Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 Conference
From GlobeNewswire News Releases
Hot Penny Stocks To Buy Under $4 On Robinhood, 2 With 150%+ Targets
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
4 Penny Stocks On Robinhood Analysts Say Buy & 2 Have 100%+ Targets
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
From PR Newswire
Assembly Bio/Arbutus Bio Start Testing Vebicorvir/AB-729 Triplet Therapy In HBV Infection
Tags Hepatits B FDA Small Cap
From Benzinga
Thinking about buying stock in GameStop, LivePerson, Etsy, Dynavax Technologies, or Arbutus Biopharma?
From PR Newswire
Thinking about buying stock in Vistagen Therapeutics, Adapthealth, PainReform, Arbutus Biopharma, or AIM ImmunoTech?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.